PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business
Nirvana Announces First Production of Psilocybin and Psilocin Nirvana Life Sciences (NIRV), a recently listed
Magic Mushrooms Have Over 80 Different Species—And Their DNA Is Now Available Online Medicinal Genomics
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets Terran Biosciences,
Nue Life Health raises $23M Series A Led by Obvious Ventures for psychedelics platform Nue
Psyence and Filament Health Enter Into Exclusive Licensing Agreements For Natural Psilocybin Products Filament Health
Irwin Naturals strikes deal to acquire chain of ketamine treatment clinics in Florida and Mexico
Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder Wesana Health (WESA)
Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other
Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT Cybin (CYBN) found
Numinus Wellness (NUMI) is acquiring Novamind (NM) for C$26.2M or $0.44 per share, a 51%
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
Red Light Holland to Purchase 100 Acres of Farmland in Ontario, Canada as Its Mushroom
CATALYST Summit 2022 is bringing together leaders of the psychedelic community (including everyone’s fav mycologist,
Biomind Labs to Commence Commercial Clinical Trial on Its Proprietary Mescaline Candidate BMND06 Biomind Labs
Novamind Expands Group Therapy Model Novamind (NM) is piloting a group therapy model for psychedelic
Tryp Therapeutics Initiates Enrollment for Binge Eating Disorder Study in Partnership with University of Florida
Core One Labs to Investigate Soliciting Investment and Potential Takeover Opportunities Mind Cure Health (MCUR)
MYND Life Sciences Executes a Non-Binding MOU with Tidal Psychedelics MYND Life Sciences (MYND) entered into
Awakn Life Sciences Receives Regulatory Approval for Flagship Clinic in London to Begin Delivering Treatments
Doseology Announces Frankfurt Stock Exchange Quotation Doseology (MOOD), a BC-based company that sells functional mushrooms
Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety Novamind (NM) announced that
Albert Labs (CSE:ABRT) Closes $4.7m Private Placement; Begins Trading on the Canadian Securities Exchange Albert
Blackhawk’s MindBio Therapeutics Invests NZ$2.3 Million to Fast Track Psychedelic Microdosing Phase 2 Clinical Trials
